Predictive Value of FcR Polymorphisms: A Further Step on the Long and Winding Road to Application.
The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia2Cancer Bio-Immunotherapy Unit, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy.
Riccardo
R
Dolcetti
D001943:Breast Neoplasms; D006801:Humans; D011743:Pyrimidines; D018719:Erb-b2 Receptor Tyrosine Kinases; D017452:Receptors, IgG; D000068878:Trastuzumab
D011743:Pyrimidines; D018719:Erb-b2 Receptor Tyrosine Kinases; D017452:Receptors, IgG; D000068878:Trastuzumab; C445323:FCGR2A protein, human; C496124:FCGR3A protein, human; C012626:B 31; C508053:ERBB2 protein, human